🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and tolerability of: *...
Status
Recruiting
Location
Research Site
Start Date
2022-10-26
Trial ID
NCT05536141
Treatments Being Tested
The main goal of this first-in-human (FIH) study is to learn about the safe...
Status
Recruiting
Location
Stanford Cancer Center
Start Date
2024-07-26
Trial ID
NCT06532565
Treatments Being Tested
Participants will have a diagnosis of dedifferentiated liposarcoma (DDLS) t...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2023-05-23
Trial ID
NCT05886634
Treatments Being Tested
The purpose of this study is to see whether the drug casdatifan is safe and...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-03-09
Trial ID
NCT07397611
Treatments Being Tested
This randomized phase 2 open-label study will evaluate the safety and effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-05-28
Trial ID
NCT04262856
Treatments Being Tested
The primary objective of this study is to compare the effect of zimberelima...
Status
Active Not Recruiting
Location
Innovative Clinical Research Institute
Start Date
2022-10-12
Trial ID
NCT05502237
Treatments Being Tested
This is a phase 2 study to evaluate zimberelimab (AB122) combined with domv...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-02-08
Trial ID
NCT04736173
Treatments Being Tested
This study will evaluate the safety and effectiveness of a combination of s...
Status
Recruiting
Location
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
Start Date
2023-07-01
Trial ID
NCT05915442
Treatments Being Tested
The purpose of this study is to test the safety and tolerability of chemoth...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-12-31
Trial ID
NCT04892875
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation, and dose-expansion, with a ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-11-06
Trial ID
NCT04104672
Treatments Being Tested